---
figid: PMC3960190__oncotarget-05-0078-f001
figlink: /pmc/articles/PMC3960190/figure/F1/
number: F1
caption: 'In the canonical pathway, the three TGF-β ligand isoforms, TGF-β1, TGF-β2,
  and TGF-β3, are synthesized as precursors and bind to form the latent TGF-β complex
  before being secreted[]. After extracellular activation, TGF-β ligands bind to the
  membranous TGF-β type III receptor or the TGF-β type II receptor (TGF-βRII) homodimers
  with high affinity. TGF-βRII binding allows dimerization with TGF-β type I receptor
  (TGF-βRI) homodimers, activation of the TGF-βRI kinase domain and signal transduction
  via phosphorylation of the C-terminus of receptor-regulated SMADs (R-SMAD), SMAD2
  and SMAD3. The TGF-βR dimer then forms a heterotrimeric complex with SMAD4 which
  translocates and accumulates in the nucleus[, ]. TGF-β dependent signalling can
  activate or repress hundreds of target genes through the interaction of SMADs with
  various transcription factors (TF). SMAD activities are regulated through several
  mechanisms: SMAD2/3 nucleocytoplasmic shuttling, binding to anchor proteins such
  as SARA, phosphorylation (e.g., by ERK, JNK, and p38 MAPK), Smurf (SMAD-ubiquitination-regulatory
  factor)-dependent degradation, or via expression of inhibitory SMAD6 and SMAD7[].
  In the non-canonical pathway, TGF-β signalling activates SMAD-independent pathways
  such as PI3K/AKT, MAPK pathways (ERK, JNK, and p38 MAPK) as well as NF-κB, Rho/Rac1,
  Cdc42, FAK, Src, Abl[]. Moreover, transversal signalling, especially at the SMAD
  level, allows TGF-β pathway activation to integrate signals from integrins, Notch,
  Wnt, TNF-α, or EGF-dependent pathways as well as signals from cellular processes
  such as the cell cycle or apoptosis machineries[]. The TGF-β signalling pathway
  thus has pleiotropic functions regulating cell growth, differentiation, apoptosis,
  cell motility, extracellular matrix production, angiogenesis and cellular immune
  response[].'
pmcid: PMC3960190
papertitle: Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.
reftext: Cindy Neuzillet, et al. Oncotarget. 2014 Jan;5(1):78-94.
pmc_ranked_result_index: '24491'
pathway_score: 0.9627378
filename: oncotarget-05-0078-f001.jpg
figtitle: Perspectives of TGFB inhibition in pancreatic and hepatocellular carcinomas
year: '2014'
organisms:
- Mus musculus
- Rattus norvegicus
- Hepatitis B virus
- Citrus macrophylla
- Homo sapiens
ndex: 60fa76dc-deb7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3960190__oncotarget-05-0078-f001.html
  '@type': Dataset
  description: 'In the canonical pathway, the three TGF-β ligand isoforms, TGF-β1,
    TGF-β2, and TGF-β3, are synthesized as precursors and bind to form the latent
    TGF-β complex before being secreted[]. After extracellular activation, TGF-β ligands
    bind to the membranous TGF-β type III receptor or the TGF-β type II receptor (TGF-βRII)
    homodimers with high affinity. TGF-βRII binding allows dimerization with TGF-β
    type I receptor (TGF-βRI) homodimers, activation of the TGF-βRI kinase domain
    and signal transduction via phosphorylation of the C-terminus of receptor-regulated
    SMADs (R-SMAD), SMAD2 and SMAD3. The TGF-βR dimer then forms a heterotrimeric
    complex with SMAD4 which translocates and accumulates in the nucleus[, ]. TGF-β
    dependent signalling can activate or repress hundreds of target genes through
    the interaction of SMADs with various transcription factors (TF). SMAD activities
    are regulated through several mechanisms: SMAD2/3 nucleocytoplasmic shuttling,
    binding to anchor proteins such as SARA, phosphorylation (e.g., by ERK, JNK, and
    p38 MAPK), Smurf (SMAD-ubiquitination-regulatory factor)-dependent degradation,
    or via expression of inhibitory SMAD6 and SMAD7[]. In the non-canonical pathway,
    TGF-β signalling activates SMAD-independent pathways such as PI3K/AKT, MAPK pathways
    (ERK, JNK, and p38 MAPK) as well as NF-κB, Rho/Rac1, Cdc42, FAK, Src, Abl[]. Moreover,
    transversal signalling, especially at the SMAD level, allows TGF-β pathway activation
    to integrate signals from integrins, Notch, Wnt, TNF-α, or EGF-dependent pathways
    as well as signals from cellular processes such as the cell cycle or apoptosis
    machineries[]. The TGF-β signalling pathway thus has pleiotropic functions regulating
    cell growth, differentiation, apoptosis, cell motility, extracellular matrix production,
    angiogenesis and cellular immune response[].'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK13
  - PIK3R6
  - MTOR
  - CDKN2A
  - MAPK14
  - MAPK12
  - TP53
  - PIK3R3
  - ARAF
  - PIK3R4
  - MAPK11
  - AKT3
  - SMAD7
  - RAF1
  - FAM126A
  - MAP2K2
  - MAPK8
  - PIK3R5
  - TGFB2
  - BRAF
  - MAP2K1
  - TGFB1
  - GRB2
  - MAPK1
  - AKT2
  - PIK3CG
  - PIK3CB
  - PIK3CD
  - MAPK10
  - MAPK3
  - PIK3CA
  - AKT1
  - ROCK2
  - SMAD4
  - SMAD6
  - MAPK9
  - HRAS
  - NRAS
  - TGFBR2
  - TKTL1
  - SMAD2
  - SMAD3
  - TGFB3
  - KRAS
  - ROCK1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: SMAD6/7
  symbol: SMAD7
  source: hgnc_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK2
  entrez: '9475'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: SMAD6/7
  symbol: SMAD6
  source: hgnc_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TGFB-RII
  symbol: TGFBR2
  source: hgnc_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TKR
  symbol: TKR
  source: hgnc_alias_symbol
  hgnc_symbol: TKTL1
  entrez: '8277'
- word: SMAD2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: SMAD3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: TGFB
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ROCK
  symbol: ROCK
  source: bioentities_symbol
  hgnc_symbol: ROCK1
  entrez: '6093'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3960190__F1
redirect_from: /figures/PMC3960190__F1
figtype: Figure
---
